BusinessLupin's USA facility gets 6 USFDA observations The Pre-approval inspection was conducted from 7 May 2024 to 17 May 2024, and closed with an issuance of a Form-483 with six observations By Palak Vaghela 20 May 2024Share Twitter Share Whatsapp LinkedIn
Health & FitnessLupin's COVID-19 drug Molnupiravir launched in India The Medicine Controller General of India (DCGI) has issued the drug emergency use authorization for the treatment of adult COVID-19 patients By Palak Vaghela 07 Jan 2022Share Twitter Share Whatsapp LinkedIn